Sale!

Lung Cancer Panel 1 EGFR ALK1 Test Cost

Original price was: 4,800 د.إ.Current price is: 3,600 د.إ.

-25%

The “Lung Cancer Panel 1 EGFR ALK1 Test” is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify specific genetic mutations within the EGFR (Epidermal Growth Factor Receptor) and ALK1 (Anaplastic Lymphoma Kinase) genes. These mutations are significant markers for non-small cell lung cancer (NSCLC), which is the most common type of lung cancer. Identifying the presence of these mutations can greatly influence the treatment approach, enabling healthcare providers to tailor targeted therapies that are more effective and have fewer side effects compared to conventional treatments.

The test is priced at 3600 AED and involves analyzing a patient’s DNA sample, typically obtained through a biopsy or a blood sample, to detect the presence of these genetic alterations. By pinpointing the exact nature of the mutation, the test not only helps in confirming a diagnosis of lung cancer but also in predicting the patient’s response to specific targeted therapies, thus playing a crucial role in personalized medicine.

DNA Labs UAE is known for its advanced diagnostic technologies and expertise in genetic testing, ensuring that the Lung Cancer Panel 1 EGFR ALK1 Test is conducted with high precision and reliability. The results from this test can provide valuable insights for oncologists, helping them to devise a more effective and customized treatment plan for their patients with NSCLC.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Lung Cancer Panel 1 EGFR ALK1 Test

At DNA Labs UAE, we offer the Lung Cancer Panel 1 EGFR ALK1 Test for the diagnosis of lung cancer. This test is designed to identify specific genetic alterations in the EGFR and ALK1 genes, which are commonly found in non-small cell lung cancer (NSCLC) patients.

Test Components

  • Paraffin embedded tissue blocks

Price

AED 3600.0

Sample Condition

Tumor tissue

Report Delivery

5-7 days

Method

FISH, Sanger Sequencing

Test Type

Genetics

Doctor

Oncology

Test Department

Pre Test Information

Pre Test Information

The Lung Cancer Panel 1 EGFR ALK1 Test can be done with a doctor’s prescription. Please note that the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Test Details

The Lung Cancer Panel 1 EGFR ALK1 Test includes testing for EGFR mutations and ALK gene rearrangements. Here is some information about these genetic alterations:

EGFR (Epidermal Growth Factor Receptor)

EGFR is a protein that regulates cell growth and division. Mutations in the EGFR gene can lead to increased receptor activity, resulting in uncontrolled cell growth and the development of cancer. EGFR mutations are commonly found in NSCLC and can be targeted with specific drugs known as EGFR inhibitors.

ALK1 (Anaplastic Lymphoma Kinase)

ALK1 is a gene that encodes for a protein called anaplastic lymphoma kinase. ALK gene rearrangements can occur in a subset of NSCLC patients, leading to the production of an abnormal ALK protein that promotes cell growth and division. ALK inhibitors are targeted therapies that specifically block the activity of the abnormal ALK protein, inhibiting the growth of cancer cells.

The Lung Cancer Panel 1 EGFR ALK1 Test is used to identify patients who may benefit from targeted therapies that specifically target these genetic alterations.

Test Name Lung Cancer Panel 1 EGFR ALK1 Test
Components Paraffin embedded tissue blocks
Price 3600.0 AED
Sample Condition Tumor tissue
Report Delivery 5-7 days
Method FISH,Sanger Sequencing
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Lung Cancer Panel 1 EGFR, ALK1] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

EGFR (Epidermal Growth Factor Receptor): EGFR is a protein that is involved in regulating cell growth and division. Mutations in the EGFR gene can lead to increased activity of the receptor, resulting in uncontrolled cell growth and the development of cancer. EGFR mutations are commonly found in non-small cell lung cancer (NSCLC) and can be targeted with specific drugs known as EGFR inhibitors.

ALK1 (Anaplastic Lymphoma Kinase): ALK1 is a gene that encodes for a protein called anaplastic lymphoma kinase. ALK gene rearrangements can occur in a subset of NSCLC patients, leading to the production of an abnormal ALK protein that promotes cell growth and division. ALK inhibitors are targeted therapies that specifically block the activity of the abnormal ALK protein, inhibiting the growth of cancer cells.

The Lung Cancer Panel 1 includes testing for EGFR mutations and ALK gene rearrangements. This panel is used to identify patients who may benefit from targeted therapies that specifically target these genetic alterations.